Illumina (NASDAQ:ILMN) PT Raised to $124.00

Illumina (NASDAQ:ILMN – Free Report) had its price target boosted by Robert W. Baird from $119.00 to $124.00 in a research note published on Wednesday, Benzinga reports. They currently have a neutral rating on the life sciences company’s stock. ILMN has been the subject of several other research reports. UBS Group boosted their price target […]

Leave a Reply

Your email address will not be published.

Previous post Robinhood Markets’ (HOOD) Neutral Rating Reiterated at Piper Sandler
Next post The Goldman Sachs Group Cuts Stem (NYSE:STEM) Price Target to $0.75